Skip to main content
. 2021 Sep 28;8:745006. doi: 10.3389/fmed.2021.745006

Table 2.

Baseline characteristics of study population grouped by sleep duration.

Sleep duration on weekdays
≤6 h 6–9 h ≥9 h p-values
(n = 1,118) (n = 5,652) (n = 1,499)
Demographic characteristics
Female 512 (45.8%) 2,874 (50.8%) 841 (56.1%) ***
Age (year) 48.5 (17.8) 33.3 (24.3) 49.1 (22.0) ***
Race ***
Mexican American 136 (12.2%) 848 (15.0%) 223 (14.9%)
Other Hispanic 105 (9.39%) 489 (8.65%) 140 (9.34%)
Non-Hispanic white 314 (28.1%) 1,907 (33.7%) 538 (35.9%)
Non-Hispanic black 367 (32.8%) 1,211 (21.4%) 335 (22.3%)
Other Race—including multi-racial 196 (17.5%) 1,197 (21.2%) 263 (17.5%)
Weight (kg) 85.2 (24.9) 65.3 (30.4) 79.3 (22.2) ***
Height (cm) 167 (10.3) 155 (22.0) 165 (9.90) ***
BMI (kg/m 2 ) 30.3 (8.10) 25.6 (8.14) 28.9 (7.29) ***
Marital status **
Married or living with partner 602 (57.6%) 1,949 (60.5%) 701 (54.1%)
Never married 199 (19.0%) 569 (17.7%) 238 (18.4%)
Widowed, divorced, or separated 245 (23.4%) 704 (21.8%) 356 (27.5%)
Comorbidities
High blood pressure 424 (37.9%) 1,181 (33.4%) 532 (35.6%) *
High cholesterol 356 (32.2%) 1,117 (31.7%) 495 (33.2%) 0.60
Diabetes ***
Yes 154 (13.8%) 487 (8.62%) 252 (16.8%)
No 926 (82.9%) 5,050 (89.4%) 1,212 (80.9%)
Borderline 37 (3.31%) 113 (2.00%) 34 (2.27%)
Failing kidneys 50 (4.79%) 100 (3.10%) 73 (5.64%) ***
Anemia 54 (4.84%) 177 (3.13%) 89 (5.97%) ***
Congestive heart failure 55 (5.27%) 85 (2.64%) 61 (4.72%) ***
Coronary heart disease 60 (5.74%) 121 (3.76%) 84 (6.49%) ***
Stroke 57 (5.47%) 118 (3.67%) 98 (7.56%) ***
Chronic obstructive pulmonary disease 71 (6.81%) 135 (4.19%) 87 (6.72%) ***
Malignancy 91 (8.71%) 334 (10.4%) 163 (12.6%) ***
Renal function
Blood Urea Nitrogen (mmol/L) 5.36 (2.28) 5.14 (2.04) 5.33 (2.26) **
Creatinine, refrigerated serum (umol/L) 82.6 (53.5) 75.1 (33.3) 79.6 (42.1) ***
eGFR (ml/min/1.73 m2) 95.8 (25.5) 103 (28.8) 95.0 (28.6) ***
Uric acid (umol/L) 330 (87.8) 320 (87.9) 319 (88.4) **
Albumin creatinine ratio (mg/g) 44.0 (223) 38.1 (294) 59.9 (365) 0.06
Metabolites of nicotine
Serum cotinine (ng/mL) 75.6 (152) 30.4 (95.9) 49.7 (122) ***
Seum hydrocotinine (ng/mL) 30.9 (82.0) 11.7 (41.6) 21.4 (58.8) ***
*

p < 0.05,

**

p < 0.01,

***

p < 0.001 using statistical methods of ANOVA and Chi-squared test.